Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Operating Expenses | 2,198 | 998 | 2,700 | 1,139 | 1,037 |
| Operating Income | -2,198 | -998 | -2,700 | -1,139 | -1,037 |
| Interest Expense | 1 | 3 | 3 | 1 | 2 |
| Pre-tax Income | -2,199 | -1,001 | -2,703 | -1,139 | -1,039 |
| Net Income Continuous | -2,199 | -1,001 | -2,703 | -1,139 | -1,039 |
| Net Income | $-2,199 | $-1,001 | $-2,703 | $-1,139 | $-1,039 |
| EPS Basic Total Ops | -0.58 | -0.30 | -1.28 | 5.46 | -1.75 |
| EPS Basic Continuous Ops | -0.58 | -0.30 | -1.28 | 6.57 | -1.70 |
| EPS Diluted Total Ops | -0.58 | -0.30 | -1.28 | 5.46 | -1.75 |
| EPS Diluted Continuous Ops | -0.58 | -0.30 | -1.28 | 6.57 | -1.70 |
| EPS Diluted Before Non-Recurring Items | -0.58 | -0.30 | -1.28 | N/A | -1.71 |
| EBITDA(a) | $-2,170 | $-970 | $-2,673 | $-1,126 | $-1,025 |